Jane Street’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Jane Street’s Portfolio LFSC Stock Details LFSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$275K	Buy	+6,160	New	+$284K	﹤0.01%	9377

Other funds holding LFSC

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Hunter Associates Investment Management Pittsburgh, Pennsylvania $860M AUM 22.54% 1-Year Est. Return

Cedar Cove Wealth Partners Bloomington, Minnesota $211M AUM 14.83% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return

Old Port Advisors Portland, Maine $500M AUM 40.17% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $59.1B AUM 42.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Jane Street's LFSC Position: Q3 2026 in Review

Jane Street opened a new position in F/m Emerald Life Sciences Innovation ETF (LFSC) in Q3 2026: 6,160 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #9377 among its holdings.

11 funds tracked by Wall St. Rank hold LFSC as of Q3 2026.

Jane Street held 6,160 shares of F/m Emerald Life Sciences Innovation ETF worth $275K as of Q3 2026.
F/m Emerald Life Sciences Innovation ETF was a new Jane Street position in Q3 2026.
F/m Emerald Life Sciences Innovation ETF made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9377 holding.
11 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.